Antibodies
10 December 2016
AC IMMUNE PARTNER GENENTECH PRESENTS IMPORTANT DATA ON ALZHEIMER’S THERAPY CRENEZUMAB10 December 2016
C2N Diagnostics Reports Phase 1 Study Results of C2N-8E12 (ABBV-8E12) – Anti-Tau Antibody – in Subjects with Progressive Supranuclear Palsy10 December 2016
BioInvent terminates current BI-505 Phase II study10 December 2016
US FDA accepts first biologics license application for AstraZeneca’s durvalumab in bladder cancer8 December 2016
Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint8 December 2016
Regeneron and Sanofi Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA7 December 2016
Novartis’ Lucentis® received EU approval in new indication – Lucentis the only treatment available for a wide range of CNV conditions7 December 2016
FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer6 December 2016
Immunomedics Introduces New Antibody-Drug Conjugate at Annual Meeting of American Society of Hematology6 December 2016
Affimed Presents New Preclinical Data on Bi- and Trispecific Immune Cell Engagers at ASH6 December 2016
Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting6 December 2016
MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference6 December 2016
MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 20166 December 2016
Preclinical Data on IMGN632, a Novel CD123-Targeting ADC, Presented at ASH Annual Meeting6 December 2016
Encouraging data of Indatuximab Ravtansine (BT-062) in combination therapy in advanced Multiple MyelomaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports